Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04274829

Enrollment

300

Registered

2020-02-18

Start date

2010-01-31

Completion date

2020-02-29

Last updated

2020-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymph Node Metastases, Thyroid Cancer

Brief summary

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Interventions

PROCEDUREThyroidecomt and lymphectomy

Patients underwent total thyroidectomy or lobectomy associated to lymph node sampling or neck lymphectomy

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients with papillary microcarcinoma of the thyroid

Exclusion criteria

Patients with thyroid nodules \> 1 cm; incomplete data

Design outcomes

Primary

Measure	Time frame	Description
Incidence of lymph node metastasis	1 year	To define the incidence of lymph node metastasis in patients with papillary microcarcinoma

Secondary

Measure	Time frame	Description
Predicrive factors of lymph node metastasis	1 year	To assesss predictive factors of lymph node metastasis

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026